Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.
about
Non-acute percutaneous coronary intervention versus medical therapy in patients with ischaemic heart diseaseEverolimus-eluting stents in interventional cardiologyEverolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomesOptical coherence tomography: from research to practiceThe impact of renal impairment on long-term safety and effectiveness of drug-eluting stentsAdvances in stent technologies and their effect on clinical efficacy and safetyVery late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.Management of Percutaneous Coronary Intervention Complications.The 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial: study protocol for a randomized controlled trialComparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry.New-Generation Coronary Stents: Current Data and Future Directions.Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.The resolute™ integrity zotarolimus-eluting stent in coronary artery disease: a review.Safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent in an all-comers population cohort.Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity.Everolimus-eluting stents improve vascular response in a diabetic animal model.Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with CoronarComparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry.Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysisReal-world safety and effectiveness outcomes of a zotarolimus-eluting stent: final 3-year report of the RESOLUTE International study.Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminComparison of 9-month angiographic outcomes of Resolute zotarolimus-eluting and everolimus-eluting stents in a real world setting of coronary intervention in Korea.Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial.Comparison of zotarolimus- and everolimus-eluting coronary stents: final 5-year report of the RESOLUTE all-comers trial.Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus eluting stent in a consecutive cohort of patients at a tertiary medical center.Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.Comparing Stent Thrombosis associated with Zotarolimus Eluting Stents versus Everolimus Eluting Stents at 1 year follow up: a systematic review and meta-analysis of 6 randomized controlled trials.Safety and efficacy of overlapping homogenous drug-eluting stents in patients with acute myocardial infarction: results from Korea Acute Myocardial Infarction Registry.Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis.Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.Coronary stent thrombosis: current insights into new drug-eluting stent designsBifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trialImplementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review.Almanac 2011: stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology.Investigation of enhanced hemocompatibility and tissue compatibility associated with multi-functional coating based on hyaluronic acid and Type IV collagen.Risk factors for coronary drug-eluting stent thrombosis: influence of procedural, patient, lesion, and stent related factors and dual antiplatelet therapy.Stent thrombosis is a major concern in clinical practice: A single Saudi center experienceSafety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial
P2860
Q24186673-5FDE5F92-6181-4429-9537-2CF284BFB4DCQ24630321-5292DB60-57E8-4A05-84F4-7F97840139FEQ26798582-0D461575-3A2B-4300-8D00-0018233B6531Q26991471-4415A446-6E3F-4AB8-AC83-2B904F2992BDQ28542739-ECB3BC51-2F4D-4DF9-900F-0A573653B3DAQ28972437-55E76404-42B0-4588-8D27-CFCA7ED19B03Q30251867-263FA051-3107-4DF9-9AC7-56A67FE92F9CQ30400083-667160CB-CA90-4D7A-9C80-1A24D1F56559Q30513934-B4D6A9FA-AD82-409E-9BAF-50E8B1FA0B18Q31043691-85E9D0AE-5E51-4679-914F-92AAAE5B206FQ31164040-93AB42F6-9BFE-4682-97FD-B272482668A1Q33791885-C2F1D41F-8DD8-4325-9411-B853FF706EC8Q33936124-63D760C6-C829-4886-B376-0B957EB530B9Q34002205-E1255C0D-D597-403F-8E69-E4964055D74AQ34014099-12FCD583-B0DA-4D82-9253-3DAF51B36CDFQ34076128-CEC7C485-DB08-4B37-8D03-2523106090B7Q34201662-72E9E813-CD52-420B-9FA6-3A201897F013Q34354151-AB20593C-7B71-4883-8242-9759C47B55E5Q34431992-C79A0781-ECDD-46D8-973B-B34EB54F2097Q34452943-06DEE6C4-1CE7-4819-9A82-96B3B75518FDQ34548825-A0A3FF4F-C3F4-42C0-8180-1D93220C137BQ34649311-3DBFA47B-93EE-45C1-A82C-212862528B29Q34980498-7B9AA8F3-6CE7-4D9D-9417-0252121375F8Q35249476-EAB2C9F7-EF00-4A41-A94C-6B2B953B3CBBQ35831446-1BB23217-D6F2-45C0-AFC7-98EF587553AAQ35905584-2572BE63-354F-4F2D-83D7-7EFC29689A52Q36154232-A7017349-F2A1-4E1E-954E-5363CEA05C2CQ36311078-0D01565D-86A8-4C49-9FE1-D147A7BBD5CDQ36381907-9C50A46A-F9B5-4AE3-A27D-F0CCF5EA7E11Q36411732-00EB5C37-0DB1-4A01-8FDD-9AD562427B66Q36460858-4E01C18C-7147-479F-BE5F-D070D560B3F6Q36514842-3246D1AA-DF0E-4672-A8D0-A53345970A5BQ36594779-48422163-AFF0-4DAF-BC87-4AF2BF7CFEB7Q36705836-0BCCCDBE-69EF-411F-987C-BDA3CBA5FEEDQ36787252-E6B12894-8A32-48B6-8767-ABC4A09AE366Q36939415-20D4B482-1362-496D-AD4C-F2208702115CQ36995923-F735EB1E-06CE-4976-A857-2181E3C95030Q37282855-C560EAB0-403C-4393-A5FD-76E0EE27B313Q37284036-CBFD3CB7-3D0D-4B72-85DD-C6C357FCB8C0Q37377810-087806F5-6D9F-4687-A827-6A4BB53BC379
P2860
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.
@en
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.
@nl
type
label
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.
@en
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.
@nl
prefLabel
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.
@en
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.
@nl
P2093
P50
P356
P1476
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.
@en
P2093
Adrianus Johannes van Boven
Antonio Bartorelli
Axel Linke
Carlo DiMario
Carlos Macaya
Frank van Leeuwen
Ganesh Manoharan
Gert Richardt
Henning Kelbaek
Jacintha Ronden
P304
P356
10.1056/NEJMOA1004130
P407
P577
2010-06-16T00:00:00Z